At the MIT Sloan Bioinnovations Conference on February 28, hundreds gathered at the Boston Marriott Cambridge to listen to Alex Azar, President of Eli Lilly USA and afternoon keynote speaker for the event. He walked the audience through the healthcare industry from the point of view of a global biopharmaceutical leader, discussing why hard science is not easily translated to personal medicine.
At the MIT Sloan Bioinnovations Conference on February 28, hundreds gathered at the Boston Marriott Cambridge to listen to Alex Azar, President of Eli Lilly USA and afternoon keynote speaker for the event. He walked the audience through the healthcare industry from the point of view of a global biopharmaceutical leader, discussing why hard science is not easily translated to personal medicine.
Eric hao—The Tech
